Cliff Cramer, who has more than 25 years of experience in the financial services and pharmaceutical industries, has been named director of the School’s new Healthcare and Pharmaceutical Management Program.
The program draws on the University’s strengths in medicine, the social sciences and law, and its location in New York, home to some of the world’s largest healthcare organizations and major investors in this complex industry. Cramer will work with the School’s faculty to structure the program’s curriculum and build a forum of practitioners who will offer advice and support.
“Columbia Business School is well positioned to play a leadership role in this area through our entrepreneurial mindset,” says Dean Glenn Hubbard. “New frameworks and business models are desperately needed for the industry to continue to innovate and deliver higher-value healthcare to a diverse and increasingly price-sensitive customer base.”
Cramer has served as managing director in the health care investment banking groups of Merrill Lynch and JPMorgan and as vice president of corporate planning and development at Merck & Co., Inc. He cofounded American Health Capital/VHA Enterprises, a health care financial services firm. He has also lectured at universities, including Princeton, Wharton and Rutgers and at industry executive conferences.